Roche’s alzheimer’s drug clears plaques in 28 weeks, faces 2028 test to slow memory loss

2 days ago 22

Roche’s experimental Alzheimer’s drug, trontinemab, has cleared harmful macromolecule deposits from the brains of 9 retired of 10 patients within